FEB 04, 2020 11:12 AM PST

The role of SRR in colorectal cancer

Researchers from Osaka University have recently discovered a new function of the multifunctional enzyme entitled serine racemase (SRR). According to the team’s findings, SRR plays a previously unknown role in cancer metabolism. This finding could lead the way to future anti-cancer treatments that target the enzyme in metabolic pathways.

SRR is already well known to convert L-serine into pyruvate, among other different reactions. And, interestingly, "Pyruvate is known to have an important role in cancer metabolism," explains lead author of the study Dr. Kenji Ohshima. "However, no one had previously studied how pyruvate produced by SRR is involved in cancer metabolism." This got Dr. Ohshima and the other researchers thinking.

In their study, they found that there is a higher presence of SRR in colorectal cancer cells and that cancer cells with more SRR divide faster than other cells. "This was a really exciting discovery because it showed that SRR is involved in colorectal cancer cell proliferation,” elaborates Dr. Ohshima. “When we then looked more closely at the pathway as a whole, we found that pyruvate levels were decreased in a slow-growing SRR mutant colorectal cancer cell line, suggesting that the pyruvate produced by SRR enhances the proliferation of colorectal cancer cells. This result confirmed that the metabolic pathway is integral to the progression of colorectal cancer."

The results from their study were published last month in Nature Metabolism.

Included in the publication were the findings that it was also possible to inhibit the growth of colorectal cancer by disrupting SRR in the metabolic pathway. This simultaneously demonstrated increased efficacy of drugs used to treat cancer and a subsequent reduction in tumors. While this study was conducted in mice models, the researchers are hopeful that their investigations will prove significant for humans.

"There is still work to be done to confirm that our results translate into human cancer systems," explains the senior author of the study Dr. Eiichi Morii. "However, based on these preliminary results, we expect that future strategies targeting SRR will provide effective new therapies for the treatment of colorectal cancer."

Sources: Nature Metabolism, Science Daily

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
OCT 05, 2020
Cancer
Fighting mitochondrial terminal exhaustion
OCT 05, 2020
Fighting mitochondrial terminal exhaustion
New findings reported in Nature Immunology highlight how the tumor microenvironment attacks the mitochondria of T l ...
OCT 08, 2020
Cancer
Oral cancer pain levels indicate metastasis
OCT 08, 2020
Oral cancer pain levels indicate metastasis
A new study from NYU College of Dentistry researchers provides insight as to why patients with metastatic oral cancer ex ...
OCT 12, 2020
Drug Discovery & Development
Researchers Solve Key Problem for Cancer Immunotherapy
OCT 12, 2020
Researchers Solve Key Problem for Cancer Immunotherapy
Cancer immunotherapies are becoming increasingly promising as a standard-of-care treatment. However, despite their promi ...
OCT 16, 2020
Cancer
Chronic jet lag raises cancer risk
OCT 16, 2020
Chronic jet lag raises cancer risk
We all know how horrible it feels to have a bad night of sleep. That feeling is only intensified with jet lag because ou ...
NOV 23, 2020
Cancer
Where are the geographic hotspots of high mortality rates for women with colorectal cancer?
NOV 23, 2020
Where are the geographic hotspots of high mortality rates for women with colorectal cancer?
A study published in Clinical and Translational Gastroenterology highlights the risk disparities in death rates fro ...
NOV 29, 2020
Cell & Molecular Biology
Engineering 'Smart' Cells to Kill Cancer
NOV 29, 2020
Engineering 'Smart' Cells to Kill Cancer
Cancer researchers have long been searching for a way to target cancer cells while ignoring healthy cells. A team of sci ...
Loading Comments...